M Muyan

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. ncbi request reprint Fusion estrogen receptor proteins: toward the development of receptor-based agonists and antagonists
    M Muyan
    Department of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY 14642, USA
    Mol Cell Endocrinol 182:249-63. 2001
  2. pmc The ligand-mediated nuclear mobility and interaction with estrogen-responsive elements of estrogen receptors are subtype specific
    Mesut Muyan
    Department of Biochemistry and Biophysics, University of Rochester Medical School, Rochester, New York 14642, USA
    J Mol Endocrinol 49:249-66. 2012

Research Grants

Collaborators

Detail Information

Publications3

  1. ncbi request reprint Fusion estrogen receptor proteins: toward the development of receptor-based agonists and antagonists
    M Muyan
    Department of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY 14642, USA
    Mol Cell Endocrinol 182:249-63. 2001
    ..These results show the utility of fusion receptors as models for generation of receptor-based agonists and antagonists...
  2. pmc The ligand-mediated nuclear mobility and interaction with estrogen-responsive elements of estrogen receptors are subtype specific
    Mesut Muyan
    Department of Biochemistry and Biophysics, University of Rochester Medical School, Rochester, New York 14642, USA
    J Mol Endocrinol 49:249-66. 2012
    ..Therefore, while ERs are highly mobile molecules interacting with target sites with fast kinetics, an indication of the hit-and-run model of transcription, they differ mechanistically to modulate transcriptions...

Research Grants5

  1. Toward a transcription therapy for breast cancer
    Mesut Muyan; Fiscal Year: 2010
    ..We anticipate that findings will be critical for the identification of new therapeutic targets, the development of prognostic tools and of a novel "transcription therapy" for breast cancer. ..
  2. Toward a transcription therapy for breast cancer
    Mesut Muyan; Fiscal Year: 2007
    ..We anticipate that findings will be critical for the identification of new therapeutic targets, the development of prognostic tools and of a novel "transcription therapy" for breast cancer. ..